SRTS
Sensus Healthcare Inc
2.90$
-4.0%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -44.6% | +76.8% | +44.2% | +39.0% | +28.4% | +3.2% | -64.9% | +182.4% | +64.7% | -45.2% | +71.3% | -34.3% | |
| – | -42.9% | +80.0% | +34.2% | +36.7% | +40.2% | +2.0% | -55.4% | +132.3% | +48.2% | -30.6% | +68.0% | -10.1% | |
| – | -45.4% | +75.1% | +49.8% | +40.2% | +22.5% | +3.8% | -70.1% | +223.6% | +74.4% | -52.5% | +73.8% | -51.4% | |
| – | +18.3% | -7.0% | +24.4% | +201.0% | +14.0% | +2.5% | -35.2% | -17.4% | +0.7% | +6.3% | +14.6% | +84.5% | |
| – | +13.6% | -3.9% | +118.7% | +7.3% | +10.8% | -2.9% | -0.4% | +15.2% | +9.0% | +3.0% | +38.6% | +10.2% | |
| – | +10.1% | -8.6% | +50.2% | +71.6% | +8.0% | +3.2% | -30.9% | -4.6% | +15.0% | -2.4% | +13.1% | +35.7% | |
| – | -3,001.5% | – | – | – | – | – | – | – | +260.0% | -102.6% | – | -227.4% | |
| – | -2.1% | -11.2% | +22.9% | +215.0% | +127.5% | -90.8% | -3.1% | -92.9% | +100.0% | -100.0% | – | – | |
| – | -3,537.3% | – | – | – | – | – | – | – | +579.5% | -97.7% | +1,283.7% | -206.7% | |
| – | -34.6% | +116.6% | -16,938.1% | – | – | -491.8% | – | – | – | -95.5% | +1,322.2% | -180.2% | |
| – | -3,537.3% | – | – | – | – | – | – | – | +488.6% | -98.0% | +1,270.5% | -216.1% | |
| – | -965.4% | – | -86.5% | -25,124.7% | – | – | – | – | +502.2% | -96.1% | +749.4% | -197.7% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.